Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial
NCT ID: NCT01108224
Last Updated: 2010-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
210 participants
INTERVENTIONAL
2004-01-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer
NCT00226928
Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment
NCT02600299
Understanding Shared Psychobiological Pathways
NCT00245219
Group Therapy for Primary Breast Cancer
NCT00220792
A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors
NCT01396174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psychosocial support
Psychosocial support
Psycho-social group intervention including patient-education for 6 h per week for 2 weeks and group therapy 2½ h for 8 weeks
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychosocial support
Psycho-social group intervention including patient-education for 6 h per week for 2 weeks and group therapy 2½ h for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Not speaking or understanding Danish
* Over 71 years
* Other life-threatening diseases
* Brain-damaged
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Cancer Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danish Cancer Society
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen H Boesen, MSc, Phd
Role: PRINCIPAL_INVESTIGATOR
Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100
Christoffer Johansen, DSc (Med)
Role: STUDY_CHAIR
Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Camma 2003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.